HALFLYTELY (BISACODYL; POLYETHYLENE GLYCOL 3350; POT) — FDA Approval NDA021551 (BRAINTREE)
HALFLYTELY (BISACODYL; POLYETHYLENE GLYCOL 3350; POT) — FDA Approval NDA021551 (BRAINTREE) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: HALFLYTELY; Active ingredients: BISACODYL; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; Application numb
| Brand name | HALFLYTELY |
|---|---|
| Active ingredients | BISACODYL; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE |
| Application number | NDA021551 |
| Sponsor | BRAINTREE |
| Dosage form | FOR SOLUTION, TABLET, DELAYED RELEASE |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 2 |
| First approval date | 20040510 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →